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Role for angiotensin H in an overt functional proteinuria. A partial
renal vein constriction (RVC) was induced acutely in Munich—Wistar
rats. RVC caused a marked reduction in glomerular plasma flow rate,
and rises in glomerular transcapillary hydraulic pressure difference and
efferent arteriolar resistance. These changes were associated with a
marked increase in urinary protein excretion, on average from a
baseline level of 8 to l20 mg/24 hrs per kidney. Infusion of saralasin,
an angiotensin II (All) antagonist, largely normalized these indices.
including urinary protein excretion (to 35 mg124 hrs per kidney),
despite continued RVC. In separate rats, fractional clearances of
neutral [°51]dextrans (molecular radii 18-60 A) (CDFX/CIN) were
measured. RVC caused a significant increase in CDEX/CIN for large
dextrans (44A), but not small dextrans (42A). Saralasin infusion led
to a partial return toward baseline values of COEX/CIN for the large
dextrans. On the basis of' the heteroporous membrane theory for
glomerular filtration, the glomerular sieving defect during RVC was
attributed to an increase in the relative fluid flux through a group of
large non-selective pores. A marked alteration in glomerular
microcirculatory pattern induced by enhanced action of endogenous
All in turn seemed to account largely, although not entirely, for the
impairment of glonierular size—selectivity during RVC.
Administration of either renin or All in animals has been
shown to increase urinary protein excretion by a number of
investigators [1—6]. Several lines of evidence indicate that this
renin/angiotensin—induced proteinuria is a consequence of in-
creased traffic of protein molecules across the glomerular
capillary wall [2—5, 71.
Whereas the availability of specific All inhibitors during the
past decade has uncovered an important role of endogenous All
in the altered glomerular circulation in a variety of
pathophysiologic conditions [8—15], little has been studied
about the potential causal role of endogenous All in protein-
uria. Although the magnitude of proteinuria induced by All
administration has regularly been documented to be at only a
trace level, the influence of endogenous All, acting as a local
hormone, may conceivably be more profound. The present
study tests the potential causal role of endogenous All in
proteinuria. In designing the protocol, it was felt that such a test
wotild best be pursued with use of a model characterized not
only by an enhanced action of endogenous All, but also by a
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near—normal level of GFR, since a reduction in GFR is expected
to reduce convective forces for the passage of macromolecules,
hence proteinuria may not he apparent. The latter condition
excluded many animal models for enhanced endogenous All
activity, such as acute or chronic volume contraction, reduced
renal perfusion pressure, and urinary tract obstruction [8—101.
Elevation in renal venous pressure of modest degree, on the
other hand, seemed to fulfill both of these requirements [16, 17].
In view of the recent notion that the glomerular capillary wall
is characterized, at least functionally, as a heteroporous mem-
brane comprised of small, highly selective, and large non-
selective pores 118—21], we felt it was important to measure
fractional clearances of dextrans over a wide range of molecular
sizes, including those with molecular radii larger than 40A. The
use of such a dextran mixture would allow a precise character-
ization of the qualitative and quantitative changes in the pore
population of the capillary wall.
Methods
Studies were performed in 21 Munich—Wistar rats weighing
230 to 300 g. All rats were anesthetized and surgically prepared
in a fashion routinely performed in our laboratory [22, 23]. The
left ureter was catheterized with a polyethylene tube (PE-lO) for
subsequent urine collections. Ten percent inulin in 0.9% NaCI
solution (Groups I and 2) or 9% inulin and 0.8% para-amino
hippurate (PAH) in 0.9% NaCI solution (Groups 3A and 3B)
was infused intravenously with a priming volume of 0.4 ml,
followed by constant infusion at the rate of 1.2 ml/hr. To
maintain the circulating plasma volume at the normal euvolemic
level during the experiment, each rat received isoncotic rat
plasma as described previously [22].
Microptincture studies
Using the method previously described in detail [9, 12, 13],
micropuncture measurements and collections were made in two
groups (Group I and Group 2) of animals to determine single
nephron glomerular filtration rate (SNGFR), mean glomerular
capillary hydraulic pressure (PGC). proximal tubule (Pr) and
surface efferent arteriolar hydraulic pressures (PE), femoral
arterial (CA) and efferent arteriolar (CE) plasma protein concen-
trations, single nephron filtration fraction (SNFF), initial
glomerular capillary plasma flow rate (QA), ultrafiltration coef-
ficient (K), as well as resistances of single afferent (RA) and
efferent (RE) arterioles. During partial constriction of the renal
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vein the hydraulic pressure in the main renal vein was measured
at a site between the constriction and the kidney using a
servo-null micropipette transducer system (model 3, Instrumen-
tation for Physiology and Medicine, San Diego, California,
USA) connected to a recorder (model 2200S, Gould Inc.,
Cleveland, Ohio, USA).
Group I (N = 7 rats). Ninety to 120 minutes after the
beginning of surgical preparation, measurements and collec-
tions specified above were begun and completed in the subse-
quent 45 minute interval. The left renal vein was then partially
constricted by placing a hemostatic clip (#160-856 George
Tiemann Co., Long Island City, New York, USA) on the main
renal vein to raise the venous pressure up to °°16 mm Hg
uniformly. Approximately 20 minutes after the onset of RVC,
micropuncture measurements and collections were repeated.
At the end of this second study period, an intravenous infusion
of saralasin was started at the rate of 0.3 mg/kg/hr. Following a
20 minute equilibration period from the start of saralasin
(Sigma, St. Louis, Missouri, USA) infusion, all of the above—
described measurements and collections were repeated.
Group 2 (N = 5 rats). To serve as a time—control for Group 1
animals, a separate group of rats was studied in a fashion
identical to that of Group 3, except that saralasin administration
was replaced with an infusion of vehicle alone.
Dextran clearance studies
Two groups (Group 3A and 3B) of animals were subjected to
whole kidney dextran clearance studies following surgical prep-
aration identical to that for Group 1 and 2 animals. At the
beginning of each dextran clearance measurement, the transit
time was determined by intravenous injection of 0.2 ml of
Lissamine green solution. In each study period, the [12511
dextran solution (=40,000 cpm/sl) was injected intravenously
followed by a constant infusion at the rate of 0.034 ml/min (for
preparation of dextran solution described below). Approxi-
mately five minutes after the completion of the priming injec-
tion, a continuous collection of blood was started from the
femoral artery for 20 minutes at a rate of 0.034 mI/mm using a
withdrawal pump (Model 941, Harvard Apparatus Co., S.
Natick, Massachusetts, USA). Urine was collected from the
left ureter for an equivalent time period, corrected for the
transit time. After the completion of this collection, the rat was
given a transfusion of whole blood harvested from their litter-
mates to replace blood loss during the initial dextran clearance
measurement (=0.7 ml). The blood samples were centrifuged
immediately and plasma and urine samples were separated
for subsequent analyses of dextran, inulin, PAH and urine
protein concentration, and for the calculations of fractional
dextran clearance (CDEX/CIN), whole kidney inulin (CIN) and
PAH (CPAH) clearances, and urinary protein excretion rate
(UPROTV).
Group 3A (N = 7 rats). Following the initial clearance
measurements (baseline), the left renal vein was constricted in
a fashion identical to that for the second period of Group 1
animals. Approximately 20 minutes after the onset of RVC, a
second set of clearance measurements were conducted in the
same manner as the first period.
Group 3B (N = 7 rats). In this group (five rats from Group 3A
and additional two rats separate from Group 3A), initial clear-
ance measurements were performed following a placement of
RVC, that is, in the same fashion as that of the second period of
Group 3A animals. After the completion of the measurements,
when the renal vein remained constricted, a continuous infusion
of saralasiri was started intravenously at the same rate as Group
1 animals (0.3 mg/kg/hr). Following a 20 minute equili-
bration period from the start of saralasin infusion, all of the
above—described measurements and collections were repeated.
Preparation of dextran solution and analysis
Dextran fractions with average molecular weight of 10, 40,
and 70 K daltons were used (Pharmacia Fine Chemicals,
Piscataway, New Jersey, USA). A 20 mg/mI solution containing
50.0% T-70, 37.5% T-40 and 12.5% T-10 was oxidized with Nal4
at pH 5.0 and reacted with tyramine in a borate buffer at pH 9.0.
The tyraminil—dextran was separated from unbound reactants
by gel filtration on a Sephadex G-25 column (total volume V =
42.4 ml) (Pharmacia Fine Chemicals). The purified mixture was
radiolabeled at pH 7.4 with IODO-BEADS (Pierce Chemical
Co., Rockford, Illinois, USA). Unreacted [12511 was removed
by a gel chromatography on a short disposable Sephadex G-25
column (V1 = 10 ml). The ionic strength and pH of the solution
were adjusted, and the mixture was sterilized by filtration and
stored at 4°C. The iodinated dextran solutions were used within
15 days of the date of preparation.
The fractionation of dextran into graded molecular size and
the measurement of radioactivity for graded dextrans were
performed as described previously [24, 251. In brief, separation
of dextran—containing samples of urine and plasma into narrow
(2 A) fractions of dextran was accomplished by gel permeation
chromatography using a column (VT = 194 ml, length = 64 cm)
packed with an even mixture of ACA 34 and 44 (LKB Instru-
ments Inc., Paramus, New Jersey, USA). Radioactivity of each
fraction of dextran (=l .6 ml) was, then, measured by a gamma
counter (Biogamma II, Beckman Instruments, Irvine, Califor-
nia, USA). The concentrations of each fraction of dextran was
calculated by the radioactivity and fractional volume of an
eluent.
Plasma and urine concentration of inulin was determined by
the anthrone method [26, 271 and those of PAH by the method
of Bratton and Marshall as modified by Smith et al [281. Urine
protein concentration was measured by the Coomassie Brilliant
Blue method [291. Details of the analytical procedures for
nanoliter samples obtained during micropuncture studies are
given elsewhere [6, 22, 301.
Calculations
Fractional clearance of Dextran (CDEX/C1fl) was calculated by
standard formulas. Details of the equations used for calculation
of SNGFR, ITE, SNFF, QA, RA, RE, mean glomerular
transcapillary hydraulic pressure difference ( = PGC — PT)
and Kf are also given elsewhere [22, 231. Statistical analyses
were performed by Student's I-test, where appropriate. Statis-
tical significance is defined as P < 0.05.
Membrane pore—size parameters were calculated using a
model described recently by Deen et al [181 which assumes two
functionally distinct pathways for the movement of macromol-
ecules across the capillary wall. The major pathway consists of
small pores of radius r, while the other contains pores that are
few in number but sufficiently large in radius that they exhibit
negligible selectivity even for the largest dextrans studied
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(molecular radius, 60 A). When applied to fractional dextran
clearance data in normal and nephrotic humans, this model was
found to be more satisfactory than several other heteroporous
descriptions of the glomerular barrier [181. The contribution of
the non-selective "shunt" pathway is characterized by a pa-
rameter w, which is related to the fraction of filtrate volume
passing through these large pores. Specifically, w0 is the frac-
tion of volume flow that would take place through the large
pores if all pores experienced the same net driving pressure.
The actual fraction of filtrate volume passing through the
postulated shunt is larger than the calculated value and varies
with position along the capillary, because flow through the
small pores is opposed by the colloid osmotic pressure of
capillary plasma (protein reflection coefficient near unity),
whereas that through the large pores of the shunt is not
(reflection coefficient near zero). The computation of r0 and w0
requires the values of CA, QA, , K and CI)Ex/CIN. For this
purpose dextran clearance data from Groups 3A and 3B were
used in conjunction with micropuncture data for the corre-
sponding control or experimental period in Group I. The
mathematical details of the model used, and the assumptions on
which it is based, are presented in detail elsewhere [181.
Results
Micropuncture studies (Groups I and 2)
Baseline period. Mean values for AP and a number of other
quantities related to glomerular hemodynamics and urinary
protein excretion, measured in Group I and 2 animals arc
summarized in fable 1. Values for body weight, AP, Hct and
UprotV were similar between the two groups, as were baseline
values for SNGFR, QA and the other parameters for glomerular
dynamics shown in Table 1.
Renal rein consiriction. Partial renal vein constriction of
comparable degree was induced in both Groups I and 2. As
shown in Table I, when renal venous pressure was raised to
'16.0 mm Hg by RVC, QA decreased markedly in both groups.
However, values for SNGFR decreased to a proportionately
less extent so that SNFF increased markedly during RVC. The
significant fall in QA and rise in SNFF were associated with a
marked and significant elevation in P. following RVC. Since
PT remained essentially unchanged, P increased significantly
in response to RVC. In addition to these rises in P0 and zP,
RVC led to directionally similar changes in E• These changes
in pressures and flows were associated with a marked and
comparable increase in R in both Group I and 2 animals
whereas RA was essentially unaffected by RVC in both groups.
In addition, values for K fell uniformly in response to RVC.
Finally, as also shown in Table 1, in response to RVC, UPROTV
increased in every Group 1 and 2 animal studied, on average by
more than tenfold.
Response to saralasin (or vehicle) during RVC. In Group I
animals,saralasin, an angiotcnsin II antagonist, was given while
the renal vein remained partially constricted. The effect of this
saralasin administration was compared with that of vehicle
infusion alone (Group 2). As shown in Table I, despite contin-
ued RVC, the administration of saralasin (Group 1), but not
vehicle alone (Group 2), served to bring many of the parameters
for glomerular hernodynamics to or toward baseline, pre-RVC
levels. Thus, in addition to the changes in QA and SNFF, PGU
declined markedly to values virtually identical to those mea-
sured prior to RVC. Together with a near constancy in PT,
Table 1. Summary of systemic blood pressure, urinary protein excretion and
group I and 2 rats
various parameters for glornerular hemodynamics
K1
measured in
A FGC P1 3P Ph CA C
g/dl SNFF
SNGIR
nt/mm
RA Rh
•mm mm
Hg/nI
nl/
mm mm
Hg
Het/i U0,Vmg/24 hrsmm Hg
Group I (N — 7 rats)
Baseline 108 49
1
16
1
33
I
19
2
5.7 8.3 0.31
0.1 0.2 0.02
43.7 46
4.7 18
0.24 0.14
0.04 0.03
6.72
0.72
47.2
1.4
8
1
RVC 107 59
I
17
2
42
1
23
2
5.5 8.8 0.37
0.1 0.2 0.02
38.7 105
4.2 13
0.25 0.23
0.03 0.03
2.82
0.30
48.5
1.7
133
25
RVC + Saralasin 1043 502 161 341 221 5.5 7.7 0.290.1 0.2 0.02 40.6 395.3 14 0.21 0.12t).04 0.01 4.980.60 48.51.5 348
P valueb >50 <.001 >10 <.001 <.05 <.00! >05 <.01 <.05 <.005 >10 <.005 <.005 >05 <.001
P value'- >10 <.00l >40 <.001 >20 >50 <.01 <.01 >40 <.01 >10 <.005 <.005 >50 <.001
Group 2 (N = 5 rats)
Baseline 113 47
1
14
I
33
I
18
I
5.4 7.9 0.31
0.1 0.3 0.03
44.0 11
6.3 33
0.27 0.15
0.05 0.04
5.64
0.96
46.3
0.8
8
2
RVC 112 61
2
18
2
44
2
23
2
5.4 8.9 0.39
0.1 0.2 0.02
37.6 98
3.4 14
0.29 0.27
0.04 0.04
2.52
0.84
47.5
0.4
109
12
RVC + vehicle 113 60
1
17
2
43
2
21
1
5.4 8.9 0.39
0.2 0.2 0.02
36.3 96
4.1 17
0.33 0.29
0.04 0.04
2.82
0.54
47.1
0.5
104
19
P valu&' >50 <.01 >20 <.025 <.05 >40 <.00! <.01 >10 <.05 >40 <.005 <.01 >20 <.001
P value >50 >40 >40 >20 >10 >50 >50 >50 >50 >50 >05 >50 >50 >50 >40
Values expressed as mean SE. RVC, renal vein constriction. Values for n/P were found to be less than 1.0 in 4 Group I rats during
Baseline, 6 during RVC and 6 during RVC + Saralasin, 4 Group 2 rats during Baseline and 5 during RVC and RVC + Vehicle. Under these
circumstances, unique K1 values were calculated and pooled with minimum K1 values to obtain average values. Urinary protein excretion rate
(U,0,V) was determined on urine samples collected over a period of —20 mm, and expressed as mg per 24 hours.
Student's 1-tests were performed for the difference between Baseline vs. RVC.
RVC vs. RVC + Saralasin (or Vehicle).
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Table 2. Summary of whole kidney clearance and urine protein
excretion data
AP UPR0TV CIN
mm Hg mg/24 hrs mi/mm
I I
20 30 40 50 60
Effective molecular radius
Fig. 1. Semilogarithmic presentation of the relationship between the
effective molecular radius of the dextran and the sieving coefficient of
dextran (fractional clearance of dextran). A. Values for baseline
(control) period (-0-) and RVC period (-A-). The values of sieving
coefficient, molecular radii greater than 44 A (except for 46 A) are
significantly elevated in RVC period. B. Values for RVC period (-A-)
and RVC + saralasin—treated period (-LI-). Those values of molecular
radii greater than 46 A are significantly decreased during saralasin
infusion. Symbol (*) indicates statistical significance at P < 0.05.
105
108
>0.40
Group 3A
Baseline
RVC
pa
Group 3B
RVC
RVC + saralasin
pa
l0
4
110
17
<0.005
CPAH
mi/mm
3.0
0.4
2.2
0.4
<0.05
2.2
0.3
2.4
0.4
>0.50
0.90
0.08
0.73
0.12
>0.10
0.76
0.25
0.81
0.09
>0.50
108 112
20
109 43
18
>0.50 <0.05
1
0.1
0.01
0.00 1
A
B
**
a
C
a,
a
ci,00
C
>
a,
(/)
a
cc
C
a,
C.,
a,0a
0)C
>
a,
U,
20 30 40 50 60 (A)
Effective molecular radius
Values are expressed as mean SE.
a Student's t-tests were performed for the changes between the two
periods within each group
.P also fell with saralasin to levels indistinguishable from
pre-RVC levels.
—
In association with the marked rise in QA and fall in P0c, RE
fell significantly during saralasin, essentially to values observed
prior to RVC while RA was again unaffected. The mean value
for Kf increased with saralasin infusion. In addition, saralasin
infusion led to a marked reduction in UPROTV, on average to
aa25% of the pre-saralasin RVC period.
In contrast to these changes observed with saralasin, infusion
of vehicle alone in Group 2 animals with continued RVC failed
to affect any of the glomerular parameters and UPROTV (Table
1).
Dextran clearance studies (Groups 3A and 3B)
Values for AP, CIN, and CPAH measured in Group 3A and 3B
animals are shown in Table 2. In Group 3A, RVC resulted man
increase of UPROTV, on average from 10 to 110 mg/24 hrs. AP
and C1, did not change significantly in response to RVC
whereas CPAH did.
In Group 3B animals the administration of saralasin in the
second study period (following initial RVC period), resulted in
a significant reduction in UPROTV, on average from 112 to 43
mg/24 hrs. AP and CIN did not change significantly, and CPAH
increased slightly, but not significantly.
Fractional clearance values for dextrans of graded size are
given in Figures IA and lB. In Group 3A animals (Fig. 1A),
RVC resulted in a significant elevation in the value of CDEX/CIN
for dextrans with the effective molecular radii larger than 44 A
(except for 46 A) whereas no discernible changes occurred in
CDEX/CIN values for molecular radii less than 42 A. In Group 3B
animals, values for COEX/CIN were initially measured during
RVC alone and were essentially identical to those obtained
during the second study period of Group 3A for all of the
dextran molecular radii studied (Fig. 1). In response to saralasin
administration (while RVC continued), values for CDEX/CIN for
dextran molecular radii greater than 46 A fell significantly
(Group 3B) toward (but not reaching) the levels measured
during the baseline non-RVC period of Group 3A animals. In
contrast, those for dextran with molecular radii less than 40
A, were unaffected by saralasin as shown in Figure lB.
0.1
0.01
0.001
0.000 1
**
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Membrane pore parameters
Figure 2 summarizes values of the membrane parameters r5
and w0 calculated for the baseline and experimental periods.
The radius r0 of the small selective pores comprising the bulk of
the membrane and the index for fractional volume flux passing
through these pores (1-w0) were relatively unaffected by renal
vein constriction or saralasin infusion during RVC, remaining at
46 to 47 A. and 1.0, respectively, in all periods studied. By
contrast, RVC induced a tenfold increase in w0, suggesting
increased availability of the large nonselective pores. Approx-
imately half of this increase in w0 was calculated to be reversed
when saralasin was given during RVC.
Discussion
Various investigators have confirmed the presence of protein-
uria after experimental renal vein occlusion [3 1—34]. The mod-
est rise in renal venous pressure (to l6 mm Hg) induced
unilaterally by partial renal vein constriction led to a marked
rise in PGC, on average, by more than 10 mm Hg. Based on the
measurements of pressures and flows within the renal micro-
circulatory system, our calculation revealed that RE increased
markedly in response to the rise in venous pressure by nearly
twofold, whereas RA remained largely unaffected. This rise in
postglomerular vascular resistance, therefore, must have con-
tributed to the observed rise in P0. These hemodynamic
patterns largely duplicate the observations made by Dilley,
Carradi and Arendshorst, employing a similar experimental
protocol in rats [351.
It is known that renal renin release is markedly enhanced
during impedance to renal venous outflow [16. 17, 36]. To
document a potential role of angiotensin II in the markedly
altered renal circulatory dynamics during elevation in renal
venous pressure, an attempt was made in our study to inhibit
angiutensin II action by infusion of saralasin. As discussed in
the Results, angiotensin II inhibition during continued RVC led
to a reduction in P almost to the pre-constriction level. This
saralasin—induced decline in PGC was associated with a pro-
found fail in RE, while RA again remained essentially unaf-
fected. Therefore, it is this saralasin—induced decline in RF that
brought about the fall in GC and SNFF and a rise in QA to near
pre-constriction levels. This, in turn, indicates that the RVC-
induced marked alteration in renal circulatory dynamics was
not merely due to a mechanical hindrance imposed upon the
renal vein, but, instead, primarily to an intrinsic constrictive
response of the efferent arteriole caused by the enhanced action
of endogenous angiotensin II.
Of interest are our findings that the alteration in renal
hemodynamics during experimental hindrance of renal venous
outflow was associated with a development of overt protein-
uria. The magnitude uf proteinuria was far in excess of previous
experimental observations with exogenous administration of
renin or angiotensin II [2, 5—71.
The marked attenuation of RVC-induced hemodynamic alter-
ations during saralasin infusion was accompanied by a similarly
marked attenuation of proteinuria in our experimental setting.
Our observations with saralasin indicate not only that the
development of proteinuria during RVC was partially reversible
but also, that All of endogcnous origin can cause overt func-
tional proteinuria.
Effective pore radius (A)
large non-selective
pores
Fig. 2. Schematic presentation qt calculated values for membrane
parameters. Values for fractional volume flux of large non-selective
pores (Os) and those of small selective pores )l-w) calculated for an
ideal condition, that is, when C5 = 0. arc given Y axis. Calculated
values for effective pare radius of small selective pores are given on X
axis, while the pore radius of large nan-selective pore is not defined in
this model [18). A. Values obtained in control period (hatched bars) and
RVC period (dotted bars). B. Values obtained in RVC period (dotted
bars) and RVC + saralasin (SAR)-treated period (hatched bars). Size
and fractional volume fluxes of small selective pores were essentially
unchanged in the three periods studied, while index for the fractional
volume flux through large non-selective pores was markedly increased
during RVC, compared to control period (A), and partially corrected
during saralasin treatment (B).
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Theoretical models for the glomerular filtration of macromol-
ecules [191 predict that an increase in filtration fraction would
raise the mean concentration of macromolecules within the
glomerular capillary, which in turn increases the diffusive
transport for those molecules. When such a rise in filtration
fraction is unaccompanied by a large fall in the filtration rate, as
in the present study during RVC, an increase in convective
transport is also predicted. Indeed, in a study by Bohrer et al [61
exogenous administration of Al! was associated with a twofold
increase in urinary protein excretion accompanied by a marked
rise in GC and SNFF, a fall in QA, and an unchanged SNGFR.
This pattern is similar to that found in our study with RVC.
Moreover, the fractional clearance of neutral dextrans was
found in the study of Bohrer et alto be elevated during All
administration for the entire range of molecular radii studied
(18A to 42A). In the present study, the behavior of dextran
fractions of larger molecular radius (42A to 60A) were exam-
ined. Whereas fractional clearance of smaller dextrans (up to
42A) remained unaffected throughout the present study, a
significant increase in CDEX/CIN for larger dextrans was ob-
served during RVC, a trend partially corrected during saralasin
infusion. Since the alterations in diffusive and convective
forces, such as those associated with changes in filtration
fraction, are expected to affect the transmembrane passage of
the entire ranges of macromolecules, the observed selective
increase in CDEX/CIN of larger molecular dextrans cannot be
attributed to the changes in filtration fraction alone. To obtain
further insight into the apparent impairment of glomerular
size—selectivity during RVC, membrane pore—size parameters
were estimated. Characterizing the glomerular capillary wall as
an isoporous membrane is clearly inconsistent with the ob-
served selective increases in the fractional clearances for the
largest dextrans. Instead, we adopted an approach which as-
sumes that the major portion of the glomerular barrier can be
described as an isoporous membrane, but that a small fraction
of the filtrate passes through a parallel, non-selective pathway
[18]. The fractional clearances of the larger dextrans are gov-
erned primarily by the amount of filtrate traversing the non-
selective pathway, because these molecules are too large to be
accommodated by the small—pore portion of the barrier. Ac-
cordingly, the membrane parameter (w0) describing the contri-
bution of large pores was found to increase substantially during
RYC, whereas the parameter describing the small—pores (their
radius, r0) did not change significantly. The model used for
these calculations takes into account the changes in volume and
solute fluxes with position along a glomerular capillary that
arise from changes in the concentration of plasma protein and of
the macromolecules (dextrans). Thus, it accounts for purely
hemodynamic effects such as the influence of variations in
filtration fraction, as discussed above. The finding of an eleva-
tion of w0 during RVC is therefore evidence of a defect in the
intrinsic size—selectivity of the glomerular capillary wall. As
already noted, this defect in size—selective function was par-
tially corrected when saralasin was administered during contin-
ued RVC.
A similar conclusion has been reached by Olivetti et al [37] in
their morphologic study using native ferritin. This marker
macromolecule is virtually completely restricted within the
intravascular space under normal conditions. Exogenous ad-
ministration of a hypertensive dose of All was found to result in
facilitated transport of ferritin, in that numerous native ferritin
particles were found in the urinary space. The authors con-
cluded that All caused an impairment in the size selective
property of glomerular capillary wall. By contrast, this conclu-
sion was not reached by Bohrer et at [61. In their study,
CDEX/CIN was measured only for molecular radii of 18 to 42A,
which were significantly elevated during All administration.
Using a model describing the glomerular capillary wall as an
isoporous membrane [6], the authors noted that the increase in
CDEX/CIN could be attributed largely to the observed reduction
in glomerular plasma flow rate and increased filtration fraction,
assuming K1 was not changed by All infusion.' If we restrict
our consideration similarly to small dextrans (18 to 42 A radius)
and interpret the present data using a purely isoporous model
(w0 = 0), r0 is calculated to increase by only a small amount
following RVC, from 45.1 to 46 A. This would lead us to a
conclusion similar to that of Bohrer et al [6], that changes in
membrane permselectivity were absent or certainly unimpres-
sive. For dextrans in this size range then, whether fractional
clearances increased or remained constant following All infu-
sion or stimulation of endogenous All is largely a reflection of
the precise magnitudes of the hemodynamic changes induced
by the experimental maneuvers and the extent to which K1 was
depressed. A distinct change in glomerular size—selectivity
becomes evident only when the data for larger dextrans (>42 A
radius) are examined, or when anothr large tracer (such as
ferritin) is employed.
Our observations during saralasin infusion were consistent
with the notion that an influence of angiotensin II on proteinuria
involves reversible changes in the sieving properties of the
glomerular capillary wall. The strong correlation between the
level of transmural hydraulic pressure (P) and the degree of
defect in the membrane size—selectivity observed in the present
study further suggests that the sieving defect induced by
endogenous angiotensin II may be channeled through All's
capacity to modulate the transmural pressure, which, in turn,
reflects its ability to regulate efferent arteriolar vasomotor
tone.2 The operation of such a physical regulatory mechanism
for transcapillary passage of macromolecules has been demon-
strated in other organ vascular beds [38, 39].
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Appendix
All
AP
C
CDFX/CIN Fractional clearance of dextran
CIN
CPAII
K1
P Mean pressure
4P Transcapillary hydraulic pressure difference,
Reprint requests ía Tushitnasa Yoshiaka, M.D., Division of Pediatric
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Avenue, Nashville, Tennessee 37232, USA.
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T Proximal tubule
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